PFE logo Pfizer +
Pfizer
+
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Pfizer's Revenue by Segment

In fiscal year 2024, Pfizer's revenue by segment (products & services) are as follows:

  • Biopharma Segment: $62.40 B

Learn more about Pfizer’s Revenue by Geography

Check out competitors to Pfizer in a side-by-side comparison.

Explore additional financial metrics for Pfizer.

Continue reading...

The above chart shows Pfizer's revenue percentage share by segment (products and services).

In fiscal year 2022, Pfizer's revenue by segment is as follows:

  • Biopharma Segment generated $98.99 B in revenue, representing 100% of its total revenue.

The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.

The above chart shows Pfizer's revenue percentage share by segment (products and services).

In fiscal year 2023, Pfizer's revenue by segment is as follows:

  • Biopharma Segment generated $57.19 B in revenue, representing 97.76% of its total revenue.
  • Business Innovation Segment generated $1.31 B in revenue, representing 2.24% of its total revenue.

The biggest segment for Pfizer is the Biopharma Segment, which represents 97.76% of its total revenue.
The smallest segment for Pfizer is the Business Innovation Segment, which represents 2.24% of its total revenue.

The above chart shows Pfizer's revenue percentage share by segment (products and services).

In fiscal year 2024, Pfizer's revenue by segment is as follows:

  • Biopharma Segment generated $62.40 B in revenue, representing 100% of its total revenue.

The biggest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
The smallest segment for Pfizer is the Biopharma Segment, which represents 100% of its total revenue.
Continue reading...

Summary Table

Products & Services (Percent Share) 2022 2023 2024
Biopharma Segment 100% 97.76% 100%
Business Innovation Segment - 2.24% -
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Pfizer.

In fiscal year 2024, the Biopharma Segment generated the most revenue ($62.40 B), and the Biopharma Segment generated the least revenue ($62.40 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Biopharma Segment revenue increased 9.12% ($5.21 B) from $57.19 B (in 2023) to $62.40 B (in 2024).
  • Business Innovation Segment revenue decreased -100% ($1.31 B) from $1.31 B (in 2023) to $0.00 (in 2024).
    • Continue reading...

    Summary Table

    Products & Services 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Biopharma Segment $98.99 B - $57.19 B
    42.23%
    		$62.40 B
    9.12%
    Business Innovation Segment - - $1.31 B - - -
    Total Revenue $98.99 B - $58.50 B
    40.91%
    		$62.40 B
    6.67%

    Frequently Asked Questions

    What was Pfizer's largest product segment last year?

    In fiscal year 2024, Biopharma Segment revenue reached $62.40 Billion, representing 100% of Pfizer's total revenue and making it the largest segment for the company.

    Which product segment experienced the highest growth for Pfizer last year?

    The Biopharma Segment segment is Pfizer's highest growth segment, with a revenue growth of +9.12% in 2024 compared to 2023.

    Related company

    Revenue Ranking

    Revenue Ranking

    Related

    Submit feedback to Bullfincher